Novavax

NVAX · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Total Revenue

$147M

Previous year: $88.3M

+66.6%

EPS

$0.11

Previous year: -$0.51

Previous year: $78.3M

-56.4%

Interest expense

$5.82M

Previous year: $7.59M

Previous year: $1.56B

-24.6%

Loading...

Novavax

Unlock previous datapoints

Upgrade

Novavax

Unlock previous datapoints

Upgrade

Novavax Revenue by Segment

Revenue by Segment

Product sales Revenue

CapyFin.com

Licensing & other Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$1.38B

P/E Ratio

3.98

Sector

N/A

Industry

N/A

52-Week High

$11.1

52-Week Low

$5.37

R&D expenses

$75.9M

SG&A expenses

$34.1M

Interest expense

$5.82M

Other income, net

$9.5M

Income tax expense

$376K

Products

Get in Touch

Resources

Novavax

Novavax

Novavax

Novavax Revenue by Segment

Revenue by Segment

Product sales Revenue

Licensing & other Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics